Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel Cell Carcinoma von Sauer, C.M, Haugg, A.M, Chteinberg, E, Rennspiess, D, Winnepenninckx, V, Speel, E.-J, Becker, J.C, Kurz, A.K, zur Hausen, A

Volltext

Merkel cell carcinoma - pathogenesis, clinical aspects and treatment von Schrama, D., Becker, J.C.

Volltext

The predictive and prognostic significance of cell‐free DNA concentration in melanoma von Váraljai, R., Elouali, S., Lueong, S.S., Wistuba‐Hamprecht, K., Seremet, T., Siveke, J.T., Becker, J.C., Sucker, A., Paschen, A., Horn, P.A., Neyns, B., Weide, B., Schadendorf, D., Roesch, A.

Volltext

Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients von Guerrero, D.M, Becker, J.C, Eckstein, E.C, Kundrapu, S, Deshpande, A, Sethi, A.K, Donskey, C.J

Volltext

Costs for health care of Holstein cows selected for large versus small body size von Becker, J.C., Heins, B.J., Hansen, L.B.

Volltext

31 MCPyV and the immune system: Target and modulator von Becker, J.C, Hadrup, S.R, Schrama, D, Ritter, C

Volltext

The Tumour Microenvironment As a Barrier for Immune Destruction of Cancer von Becker, J.C.

Volltext

70INTHE TUMOUR MICROENVIRONMENT AS A BARRIER FOR IMMUNE DESTRUCTION OF CANCER von Becker, J.C.

Volltext

Merkel cell carcinoma von Becker, J C

Volltext

Decline of programmed death‐1‐positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade von Gambichler, T., Schröter, U., Höxtermann, S., Susok, L., Stockfleth, E., Becker, J.C.

Volltext

1133P Only early adjuvant radiotherapy, particularly of the tumor bed rather than the lymph node region, improves prognosis in Merkel cell carcinoma: Results from the prospective G... von Becker, J.C., Leiter-Stoppke, U., Gesierich, A., Ulrich, C., Kähler, K.C., Pfoehler, C., Gambichler, T., Wolf, I., Herbst, R., Meier, F., Hassel, J.C., Meiß, F., Mohr, P., Terheyden, P., Zouboulis, C., Stang, A., Galetzka, W., Ugurel-Becker, S., Lodde, G.C.

Volltext

Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma von Ugurel, S., Schadendorf, D., Horny, K., Sucker, A., Schramm, S., Utikal, J., Pföhler, C., Herbst, R., Schilling, B., Blank, C., Becker, J.C., Paschen, A., Zimmer, L., Livingstone, E., Horn, P.A., Rebmann, V.

Volltext

Bullous pemphigoid after SARS‐CoV‐2 vaccination: spike‐protein‐directed immunofluorescence confocal microscopy and T‐cell‐receptor studies von Gambichler, T., Hamdani, N., Budde, H., Sieme, M., Skrygan, M., Scholl, L., Dickel, H., Behle, B., Ganjuur, N., Scheel, C., Abu Rached, N., Ocker, L., Stranzenbach, R., Doerler, M., Pfeiffer, L., Becker, J.C.

Volltext

1090TiP A phase II, open label, multicenter study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with treatment-naïve metastatic Me... von Ascierto, P.A., van Akkooi, A.C.J., Nghiem, P., Hermann, F., Henneberg, J-P., Becker, J.C.

Volltext

Supplemention of mitochondria targeted antioxidants during mouse embryo culture has significant effects on embryo quality and mitochondrial DNA copy number von Becker, J.C., Pasquariello, R., Schoolcraft, W.B., Krisher, R.L.

Volltext

1087MO A single arm phase II, multicenter trial to evaluate the clinical activity and safety of avelumab plus cetuximab in unresectable stage III or IV cutaneous squamous cell carc... von Becker, J.C., Schilling, B., Leiter-Stoppke, U., Zimmer, L., Hassel, J.C., von Wasielewski, I., Ziemer, M., Fluck, M., Meier, F., Spillner, A., Gesierich, A., Eigentler, T., Livingstone, E., Albers, M., Angela, Y., Gutzmer, R.

Volltext

SARS‐CoV‐2 spike protein is present in both endothelial and eccrine cells of a chilblain‐like skin lesion von Gambichler, T., Reuther, J., Stücker, M., Stranzenbach, R., Torres‐Reyes, C., Schlottmann, R., Schmidt, W.E., Hayajneh, R., Sriram, A., Becker, J.C.

Volltext

784O Adjuvant nivolumab (NIVO) alone or in combination with ipilimumab (IPI) versus placebo in stage IV melanoma with no evidence of disease (NED): Overall survival (OS) results of... von Schadendorf, D., Hassel, J.C., Fluck, M., Eigentler, T., Loquai, C., Haferkamp, S., Gutzmer, R., Meier, F., Mohr, P., Hauschild, A., Menzer, C., Kiecker, F., Dippel, E., Simon, J-C., Conrad, B., Garbe, C., Körner, S., Becker, J.C., Zimmer, L., Livingstone, E.

Volltext

787O Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC): Disease-free survival (DFS) results from ADMEC-O, a randomi... von Becker, J.C., Ugurel, S., Leiter-Stoppke, U., Meier, F., Gutzmer, R., Haferkamp, S., Zimmer, L., Livingstone, E., Eigentler, T., Hauschild, A., Kiecker, F., Hassel, J.C., Mohr, P., Fluck, M., Thomas, I., Garzarolli, M., Grimmelmann, I., Drexler, K., Eckhardt, S., Schadendorf, D.

Volltext

1153TiP A phase II, open label study to investigate the efficacy and safety of domatinostat in combination with avelumab in patients with advanced unresectable/metastatic Merkel ce... von van Akkooi, A.C.J., Ascierto, P.A., Becker, J.C., Nathan, P., Nghiem, P., Ostermeier, U., Reimann, P.G., Hermann, F.

Volltext